ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 224

$390K Total Retail Price of All Prescriptions

Rank: 31 out of 224

331 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

8% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
WARFARIN SODIUM 387 345 1 10
FUROSEMIDE 289 257 2 5
METOPROLOL TARTRATE 285 251 3 7
LISINOPRIL 273 232 4 2
AMLODIPINE BESYLATE 246 220 5 8
OMEPRAZOLE 228 194 6 3
SIMVASTATIN 224 184 7 1
LEVOTHYROXINE SODIUM 187 144 8 4
METFORMIN HCL 184 159 9 9
TRAZODONE HCL 132 103 10 20
SERTRALINE HCL 121 97 11 17
ATENOLOL 114 92 12 13
DONEPEZIL HCL 113 113 13 36
HYDROCHLOROTHIAZIDE 109 89 14 6
GABAPENTIN 91 76 15 14
TAMSULOSIN HCL 89 77 16 30
CITALOPRAM HBR 88 72 17 15
GLIPIZIDE 87 72 18 69
PANTOPRAZOLE SODIUM 86 65 19 27
NAMENDA 85 85 20 65
OXYCONTIN 83 41 S2 21 57
RANITIDINE HCL 76 73 22 29
LOVASTATIN 76 56 22 33
ATORVASTATIN CALCIUM 72 60 24 16
SUBOXONE 71 0 25 31
LANTUS 66 36 26 43
HYDROCODONE-ACETAMINOPHEN 63 56 S3 27 12
POTASSIUM CHLORIDE 62 43 28 24
CARBIDOPA-LEVODOPA 62 62 28 80
ALLOPURINOL 61 54 30 40
PRAVASTATIN SODIUM 57 51 31 21
LEVOFLOXACIN 57 44 31 89
AMOX TR-POTASSIUM CLAVULANATE 56 41 33 162
FLUOXETINE HCL 54 34 34 37
NYSTOP 54 49 34 100
DIGOXIN 52 43 36 58
GLYBURIDE 51 39 R 37 61
ESCITALOPRAM OXALATE 51 51 37 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.